HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Steenbergen Selected Research

Injections

8/2010Reduced in vivo high-energy phosphates precede adriamycin-induced cardiac dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Steenbergen Research Topics

Disease

6Ischemia
12/2016 - 04/2000
2Necrosis
05/2001 - 02/2001
1Hypoxia (Hypoxemia)
12/2016
1Cardiotoxicity
08/2010
1Cardiomyopathies (Cardiomyopathy)
08/2010
1Left Ventricular Dysfunction
08/2010
1Infarction (Infarctions)
05/2000

Drug/Important Bio-Agent (IBA)

2triphenyltetrazoliumIBA
05/2001 - 02/2001
1Free RadicalsIBA
12/2016
1Antineoplastic Agents (Antineoplastics)IBA
08/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2010
1Phosphates (Orthophosphate)IBA
08/2010
1KATP ChannelsIBA
04/2001
1Phosphocreatine (Neoton)IBA
04/2001
1Diazoxide (Hyperstat)FDA Link
04/2001
1Creatine Kinase (Creatine Phosphokinase)IBA
02/2001
14- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazoleIBA
02/2001
1p38 Mitogen-Activated Protein KinasesIBA
02/2001
1WortmanninIBA
08/2000
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
08/2000
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
08/2000
11,2-dioctanoylglycerol (diC8)IBA
08/2000
1ChloridesIBA
05/2000
1Lactic Acid (Lactate)FDA LinkGeneric
04/2000
1Glucose (Dextrose)FDA LinkGeneric
04/2000
1AcidsIBA
04/2000

Therapy/Procedure

1Injections
08/2010